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Abstract
Background: The classical candidate-gene approach has failed to identify novel breast cancer susceptibility genes.
Nowadays, massive parallel sequencing technology allows the development of studies unaffordable a few years ago.
However, analysis protocols are not yet sufficiently developed to extract all information from the huge amount of data
obtained.
Methodology/Principal Findings: In this study, we performed high throughput sequencing in two regions located on
chromosomes 3 and 6, recently identified by linkage studies by our group as candidate regions for harbouring breast cancer
susceptibility genes. In order to enrich for the coding regions of all described genes located in both candidate regions, a
hybrid-selection method on tiling microarrays was performed.
Conclusions/Significance: We developed an analysis pipeline based on SOAP aligner to identify candidate variants with a
high real positive confirmation rate (0.89), with which we identified eight variants considered candidates for functional
studies. The results suggest that the present strategy might be a valid second step for identifying high penetrance genes.
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Introduction
Breast cancer (BC [MIM #114480]) is the most frequent
malignancy among women, with approximately one million new
cases per year around the world [1]. About five percent of all BC
cases are considered to be hereditary, and mutations in either the
BRCA1 [MIM +113705] or the BRCA2 [MIM +600185] gene
account for 25–30% of these cases [2]. Thus, about 70% of BC
families remain unexplained, and are known as non-BRCA1/2
families [3]. In this regard, several linkage studies have been
performed during the last years on familial BC, and many
candidate regions that may contain BC susceptibility genes have
been described. However, mutational screenings in linkage assay-
identified regions using the classical candidate-gene approach did
not identify any clear pathogenic variants [4,5,6]. Therefore, new
strategies seem to be necessary.
Massive parallel sequencing technology allows nowadays the
development of studies unachievable a few years ago. Despite the
fact that the advantages of this technology were evidenced in each
of the published studies based on it, the analysis of all data
generated by this process remains a hard task to face. The first step
in the regular analysis protocol is based on the alignment of
millions of short sequences obtained from each run. For that
reason, during the past years many computer tools have been
developed to improve the accuracy of this process [7,8,9]. One of
the main obstacles is the specificity in the analysis of the data to
obtain the output required by any given study. For example, the
identification of novel variants, chromosomal translocations, or
transcription factor target sites are some of the aims of the many
studies that can be performed using high throughput sequencing
technologies, and each of them would require a specific analysis
pipeline.
A major success in the use of this technology was the re-
sequencing of the whole human genome, published in several
studies in the past years [10,11,12,13,14]. The results showed a
higher complexity level of the human genome, with the
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appearance of many new variants, short length insertions and
deletions and, even, small inversions. However, the amount of
time required for re-sequencing large genomes and its high
economic cost make it impractical as a common laboratory
technique. For that reason, the search for specific sequence-
enrichment protocols applicable to massive parallel sequencing has
been an important goal during these years. One of the approaches
developed [15] and improved [16] to obtain this specific
enrichment is the technique of selective exon-capture or hybrid
selection, based on high-density tiling DNA microarrays.
In a previous study, we performed a SNP-based linkage analysis
in 41 non-BRCA1/2 families and obtained several candidate
regions for containing BC susceptibility genes [17]. The large size
of the candidate regions and the high number of genes described
within them, led us to couple linkage analysis with high-
throughput sequencing-based mutational screening as a new
strategy for variation detection. In the present study, we used
hybrid selection of discrete genomic intervals on custom-designed
microarrays as an exon-specific enrichment of all the genes located
within two complete candidate regions on chromosomes 3 and 6,
that presented a suggestive linkage LOD score (LOD.2.2). We
also describe the complex analysis pipeline based on SOAP
aligner, developed to analyse all the data obtained, and present
eight variants that are candidates for playing a role in the
development of familial BC.
Results
Regions and capture
We performed a complete mutational screening via single-end
massive parallel sequencing technology on the 128 known genes
located on two different chromosomal regions, previously
described as candidates for containing a breast cancer suscepti-
bility gene [17]. The first region is located on 3q25, extends over
10.8 Mb (from 160,964 to 171,786 Kb), and contains 69 known
genes; the second region is located on 6q24 and spans 6.5 Mb
(from 146,078 to 152,515 Kb), containing 59 known genes. To
selectively sequence the coding region of these genes, we used
hybrid selection on tiling microarrays [16], which was validated
via qPCR (data not shown).
Reads, coverage and depth
DNA samples from 20 affected individuals, belonging to 9
different non-BRCA1/2 families, and 4 healthy unrelated
individuals from the control population were used for the analysis
process. More than 102 million reads were obtained from the
affected individuals and almost 22.4 million reads were obtained
from the control individuals (see Table 1). The average number of
reads per affected individual was 5.14 million, and this number
was increased to 5.21 million when control individuals were taken
into account. We used SOAP v1.0 to align our data set, obtaining
an average of 91.58% aligned sequences against the whole genome
with #2 mismatches. Among these, an average of 39.99%
matched our candidate coding regions. Thus, since the total
number of base pairs covered by the tiling array is 0.014% of the
genome length (434,039 bp), the average enrichment was
approximately 2.85 thousand times, calculated as the percentage
of the sequences aligned to the genome that successfully matched
to the candidate regions (39.99) divided by the percentage of the
genome length that candidate regions represent (0.014).
We calculated the coverage (number of bases covered after the
alignment) per individual and obtained an average of 98.25% of
candidate bases covered for the affected and the control
individuals (Table 1). We did not observe significant coverage
differences between the candidate coding regions located on
chromosomes 3 and 6. Importantly, a lack of correlation between
the coverage and the total number of sequences was observed
(r2 = 0.013, Figure S1A). However, this lack of correlation turned
into a logarithmic trend when the number of sequences aligned to
the candidate coding regions was used (r2 = 0.69, Figure S1B).
In order to know the power to confidentially detect possible
causal variants, we calculated the global depth (number of
sequences that cover a single base) for every base along the
candidate coding regions per individual. As expected, a strong
correlation (r2 = 0.96) was found between the global depth and the
number of reads aligned to the candidate coding regions (Figure
S1C). Taking into account only those bases that presented
coverage (depth .0), from both affected and controls individuals,
the mean and the median of the depth were 37 and 34
respectively, showing a strong correlation between them
(r2 = 0.98, Figure S1D).
Data quality control
a) Coverage homogeneity. We calculated the mean and the
median of the depth for stretches of 15 bases along the candidate
regions, and obtained the log-ratio of the median between each
affected individual and the control pool. The mean log-ratio for
the global data was 20.06 with a standard deviation of 0.55
(Table 2), showing a homogeneous distribution of the coverage
between affected and control individuals. We calculated the upper
and lower threshold for each individual (Table 2) and we identified
several regions where the coverage differed between the affected
individuals and the control pool (data not shown), most of them
flanking the candidate coding regions (which are usually low
coverage regions). In addition, the strong correlation (r2 = 0.99,
Figure S1E) between the median and the mean of the coverage for
these regions in the dataset supported that these differences in
coverage are not due to extreme values within the same coding
region but are due to chance, ruling out potential problems in the
capture step.
b) Score. Genotype calling accuracy was demonstrated
elsewhere (.90% of the known SNPs) by using a HapMap
sample in the exon-capture report [16]. In order to test the
suitability of our analysis pipeline when looking for unknown
polymorphisms, we used the candidate SNPs from a single family
obtained using different Depth Score (DS, see Material and
Methods) thresholds for both the affected samples and the control
pool data (Table 3). We observed that from DS =50 onwards for
the samples, the DS threshold used for the control pool data had
no effect on the number of candidate SNPs, highlighting the
specificity of our DS. In order to be as conservative as possible, we
considered that the best False Positive/False Negative (FP/FN)
relationship was for a DS .50 for samples and a DS .14 for the
control pool. Additionally, we performed an analysis using MAQ
software in a subgroup of families and we observed that there was
no correlation between MAQ variant score and Sanger
confirmation (Table 4). These results demonstrated the higher
accuracy of our analysis methodology compared to the algorithm
used by MAQ.
Variant identification
We included a first filter (see Material and Methods) in our
SOAP-based SNP-caller to discard the maximum amount of false
positives, obtaining 99% of SNP variants discarded (Figure 1). We
selected only those variants located on the chromosome of interest
for each individual, resulting in an average of 71 SNPs per
individual (Table 5). Subsequent filters (discarding homozygous
variants, comparing to controls and comparing within members of
A Novel NGS Analysis Pipeline
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the same family) discarded almost 80% of the remaining SNPs.
Then, we used a newly developed Perl script to differentiate between
described and previously undescribed SNPs and also to obtain the
functional consequences for each undescribed SNP, resulting in 5
undescribed variants per family on average. Since we observed that
one variant could have consequences for more than one transcript/
gene, subsequent filtering was performed using the consequences of
the variants instead of the variants themselves. Next, we discarded
intronic consequences and continued the analysis with exonic
consequences only (an average of 23% of the original number of
consequences). After that, each of the remaining SNPs showed only
one consequence, and in the following step we checked if the
remaining SNPs could be due to homology between different
regions. Finally, an average of 1 (6.25%) of the SNPs shared by all
the affected members of a family could be considered a strong
candidate (Table 5). Finally, 8 out of 9 candidate SNPs were
confirmed by Sanger sequencing, supporting a high real positive
confirmation rate (0.89). Information data about variant position,
gene, type of change, Alamuth prediction, and gene function from
the 8 final candidate SNPs is shown in Table 6. The mean DS for
confirmed variants was 115 (74–185), whereas the mean DS for
ruled out variants was 56.5 (56–57), which means that our DS score
is a suitable variable for the filtering process.
Regarding indel variants, we followed the same analysis pipeline
as with SNP variants. Even though 12 bp gaps were allowed
(maximum length allowed for an indel variant), an average of only
1.15 indels per individual were identified, and this number
decreased to 0.50 after comparison to the control pool of data.
Moreover, no indel was found to segregate in our family dataset.
In order to rule out the possibility that a putative causal indel
could be found in one member of a family but not in the other
members, we checked the consequences for the remaining indels
after the comparison to the control pool data for all 20 individuals
from the 9 non-BRCA1/2 families. We observed a total of 8
undescribed indel variants for the 20 individuals. Three of them
were located in intronic regions, two were located in 3’ UTR
regions, and the remaining three indels were homozygous with a
global depth = 1. Thus, no putative truncating indel was found in
our individual dataset (Table S1).
Discussion
High-throughput sequencing
The classical candidate-gene approach turned out to be a low-
efficiency tool with regard to cost and time when used for the
identification of causal genes in genetic diseases, especially when there
Table 1. Summary of high throughput sequencing data.
Number of sequences Depth
Chromosomea Family Individual Total
Aligned to whole
genome (%*)
Aligned to candidate
regions (%**)
Coverage
in % Mean Median
3 27 07S722 3,123,937 2,956,483 (94.64) 1,186,611 (40.14) 98.04 26 25
07S723 4,922,157 4,538,392 (92.20) 1,518,625 (33.46) 98.43 29 29
07S724 4,183,568 3,954,837 (94.53) 1,515,614 (38.32) 97.89 28 26
07S725 2,952,969 2,839,271 (96.15) 1,168,679 (41.16) 97.11 24 22
60 06-240 2,652,926 2,580,914 (97.29) 882,837 (34.21) 97.96 22 20
96-652 5,934,453 4,737,175 (79.82) 1,670,157 (35.26) 98.15 28 24
531 I-1408 12,228,047 11,188,204 (91.50) 4,694,871 (41.96) 99.07 57 48
I-904 4,293,087 3,585,982 (83.53) 1,531,322 (42.70) 97.50 30 22
713 07S635 7,568,672 7,442,938 (98.34) 2,793,056 (37.53) 99.11 45 44
07S636 7,160,552 6,889,152 (96.21) 2,574,119 (37.36) 98.94 43 42
6 11 04-168 5,734,052 5,599,100 (97.65) 2,459,740 (43.93) 98.57 43 42
96-265 6,240,024 6,012,522 (96.35) 2,642,942 (43.96) 98.22 35 32
40 07S576 2,006,661 1,667,648 (83.11) 779,723 (46.76) 97.11 18 17
07S581 4,016,214 3,618,178 (90.09) 1,568,060 (43.34) 97.66 25 23
929 I-1627 5,811,276 5,665,182 (97.49) 2,311,149 (40.80) 98.52 33 32
I-3345 2,602,250 2,554,051 (98.15) 1,059,131 (41.47) 98.27 23 23
990 I-1927 8,134,956 7,903,785 (97.16) 3,029,994 (38.34) 98.84 51 50
I-1928 7,922,500 7,590,406 (95.81) 2,817,358 (37.12) 99.02 49 48
1125 I-2033 2,747,911 2,666,280 (97.03) 1,105,059 (41.45) 97.87 24 23
I-4347 2,517,619 2,406,505 (95.59) 1,088,350 (45.23) 97.74 24 24
TOTAL 102.753.831 96,397,005 (93.81) 38,397,397 (39.83)
Average Affected 5,137,692 4,819,850 (93.63) 1,919,870 (40.22) 98.20 33 31
Control pool 22,390,251 18,221,565 (81.38) 7,438,610 (40.82) 99.33 111 98
Average All 5,214,336 4,775,773 (91.58) 1,909,833 (39.99) 98.25 37 34
The number of sequences and the depth values are shown for a total of 20 individuals from 9 non-BRCA1/2 families and 4 individuals from the control population
(Control pool).
achromosome in which linkage signal was found for each of the families.
*with respect to the total number of sequences, ** with respect to the numbers of sequences aligned to the whole genome.
doi:10.1371/journal.pone.0009976.t001
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is a large number of candidate genes (dozens to hundreds). For that
reason, we decided to explore the new possibilities that massive
parallel sequencing brings for the analysis of hundred of genes in the
same reaction. Moreover, in the present study we developed a solid
analysis pipeline based on SOAP aligner for variant detection in
families with a common genetic disease via high throughput
sequencing data. Hybrid selection on tiling microarrays [16] was
used for the enrichment of exonic sequences within two candidate
regions for carrying a breast cancer susceptibility gene. We analysed
the data from 20 affected individuals from 9 different non-BRCA1/2
families to perform a mutational screening of 128 known genes and,
through an exhaustive filtering process, we obtained 8 variants that
are currently under different genetic and functional studies (Table 6).
From a technical point of view, we obtained an average of 5.14
million reads per individual, which allowed reaching a mean global
depth of 336. We observed that multiplexing of the samples by using
5-base barcodes did not affect the capture step or the sequencing
process, and that it thus represents a valuable tool when the number
of sequences required to confidently cover the target region is
proportionally lower than the number of sequences obtained per lane.
We performed a CGH-like analysis obtaining the log-ratio
between the normalised depth data from every affected individual
and the control pool to confirm a homogenous distribution of the
coverage along the candidate regions. Although the results showed
that the distribution was very homogeneous, some differences in
coverage were observed mainly in regions flanking the coding
candidate regions (low coverage regions), where small and random
differences in depth value may produce bigger differences in the
Table 2. Index value parameters for coverage study.
Chr Fam Ind Mean St Dev Upper Lower
3 27 07S722 20.13 0.75 1.12 21.38
07S723 20.04 0.31 0.77 20.86
07S724 20.07 0.35 0.77 20.92
07S725 20.10 0.43 0.82 21.03
60 06-240 20.01 0.40 0.89 20.91
69-652 0.00 0.59 1.10 21.09
531 I-1408 0.05 0.53 1.08 20.97
I-904 20.31 1.83 2.02 22.64
713 07S635 20.04 0.62 1.08 21.16
07S636 20.04 0.45 0.92 20.99
6 11 04-168 20.09 0.35 0.76 20.94
96-265 20.02 0.36 0.83 20.88
40 07S576 20.05 0.73 1.18 21.29
07S581 0.00 0.41 0.91 20.91
929 I-1627 20.02 0.36 0.83 20.88
I-3345 20.09 0.36 0.77 20.95
990 I-1927 20.08 0.80 1.22 21.38
I-1928 20.03 0.63 1.10 21.16
1125 I-2033 20.03 0.44 0.91 20.97
I-4347 20.09 0.39 0.80 20.98
Global 20.06 0.55 0.99 21.11
In order to evaluate the quality of the coverage within the candidate coding
regions, we calculated an index value (Is, see Material and Methods). Mean,
standard deviation, and lower and upper thresholds for Is used in the coverage
study are shown for each affected individual and for the entire set of individuals
(Global).
doi:10.1371/journal.pone.0009976.t002
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index value. These data supported that the capture and sequencing
of the candidate regions were successfully fulfilled in the sample set.
Mutational screening
In order to identify de novo mutations, we consider that the best
option is to maintain those sequences that match equally to more
than one location, even though it could be a source of alignment
errors due to homology between regions. For that reason, we
tested two different aligners (SOAP and Mosaik), which allow the
possibility of maintaining this kind of sequences. We finally
decided to use SOAP v1.0 because its output file kept all the
information of the input data, while being able to detect SNPs and
short (gaps .1 bp) indel variants in single-end data.
The two high throughput sequencing-based mutation-detection
studies published in the literature used MAQ software for SNP-
calling [11,18]. In the first study, mutation detection was
performed comparing data from tumour and skin tissues from a
single leukaemia patient (AML [MIM 601626])[11]. The analysis
pipeline showed a high false positive rate (87.4%) when trying to
confirm final candidate SNPs. This high false positive rate
suggested that more stringent conditions were necessary to filter
the variants. For that reason, we designed two scores based on
intrinsic variant features such as base quality (QS) and depth (DS),
which were used as a first filter in our SOAP-based SNP-caller.
Although more than 99% of the variants were discarded with this
filter, the number of remaining variants suggested the need for
further refinement. For that reason, we developed a comparison-
based pipeline as previously described (see Material and Methods:
Data analysis and Figure 1). Only 1 SNP (less than 1.5% of the
variants detected in each individual, and around 6% of the
variants shared by the same family) per family on average passed
this filtering process, showing that, even after using restrictive
thresholds, additional information has to be used to select the most
probable variants (Table 5). Candidate SNPs were Sanger
sequencing validated, and finally 8 of the 9 SNPs (89%) were
confirmed. These variants had a minimum depth of 196 and a
maximum depth of 1556, of which between 9 and 70 reads
carried the variant. Quality scores were all close to 100,
corroborating Solexa’s good base-call quality in those positions.
The 8 variants, which are currently under study (including
functional characterization), are located in different genes (Table 6)
and could be considered as the final candidate SNPs. The
confirmation rate (0.89) and the lack of putatively causal mutations
wrongly discarded in the filtering process (Table S2) suggested that
our restrictive analysis pipeline successfully identified real
previously undescribed variants.
In the second mutational screening study performed using high-
throughput technology and MAQ software, the authors set up a
global exome-capture method based on microarrays and a specific
analysis pipeline, which was conceptually quite similar to ours, to
identify causal variants for a monogenic disease [18]. The analysis
pipeline was based on comparisons between data from affected
individuals, HapMap individuals, and the dbSNP database,
considering as candidates those functional variants that were not
present in HapMap sample data nor in the dbSNP database. With
a subset of our data, we performed a test using MAQ software and
our analysis pipeline and observed no correlation between MAQ
variant score and the confirmation rate (Table 4), evidencing a
lack of accuracy in MAQ’s algorithm.
Regarding indel variants, no indel fulfilled the criteria to be
considered a candidate variant, neither in our dataset (Table S1)
nor in the previously cited study. This could be due to the fact that
indel discovery on single-end data is not as accurate as with the
new paired-end technology, affecting the sensitivity of indel
detection in both studies. Similarly, we cannot discard the
possibility of missing the existence of large rearrangements due
to the limitations of single-end data. Recently published studies are
starting to demonstrate the efficiency of paired-end sequencing in
the identification of genomic rearrangements [19,20].
In another study, a complete mutational screening using Sanger
sequencing was performed on 718 genes located on chromosome
X in probandi from a set of 208 families diagnosed with X-linked
mental retardation [21]. The authors obtained 1858 coding
variants, among which 1814 (980 missense, 22 nonsense, 13 splice-
site, and 799 synonymous) were SNPs, 3 were double SNPs
(missense), and 41 were indels. However, only 18 SNPs (17
nonsense and 1 missense, less than 1% of the initial SNPs) and 15
indels located in 26 different genes resulted to be strong candidates
Table 4. Variant filtering results using MAQ software.
Chr Family
Position
(hg18) Gen Reference Variant MSa Consequence
Sanger
confirmation
3 27 170968060 TERC
[MIM:602322]
G C 255/39 NON_SYNONYMOUS_CODING No
531 162443032 NMD3
[MIM:611021]
A G 16/55 NON_SYNONYMOUS_CODING No
6 531 150094561 NUP43
[MIM:608141]
C T 38/11 STOP_GAINED Nob
713 149763387 SUMO4
[MIM:608829]
A G 50/50 NON_SYNONYMOUS_CODING No
990 146761618 GRM1
[MIM:604473]
C T 93/80 NON_SYNONYMOUS_CODING Yes
150205485 LRP11c T C 55/77 NON_SYNONYMOUS_CODING Yes
151202809 PLEKHG1c G A 63/46 NON_SYNONYMOUS_CODING Yesd
A lack of correlation between MAQ score (MS) and Sanger sequencing confirmation was observed, since variants showing a MS =255 (maximum) were not confirmed
whereas others with a MS = 55 were validated.
aMAQ score for individual 1/individual 2.
bvariant selected in a non-candidate chromosome for this family because of the truncating effect.
cNo MIM reference [25].
drecently described in the Ensembl database.
doi:10.1371/journal.pone.0009976.t004
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for being involved in X-linked mental retardation. Similarly, our
results showed that around 1% of the initial SNP variants obtained
via high throughput sequencing could be considered candidates
(Table 6). Because no truncating mutations passed our filters,
further functional studies are required to assess whether any of the
confirmed variants is ultimately a causal mutation, specifically
those variants considered of interest because of their functional
implications (missense and 3’UTR) and gene function.
In summary, we designed an integral analysis pipeline for
mutational screening via SOAP v1.0 that resulted in a low false
positive rate with a low probability of discarding real positive
variants, with which we identified 8 candidate variants that are
currently under functional characterization. We consider that the
present strategy might be a valid second step for identifying high
penetrance genes, specifically when the regions of interest show
significant evidence of linkage.
Materials and Methods
Ethics Statement
All patients provided written informed consent for the
collection of samples and subsequent analysis. We obtained
ethics approval for this study from the ethics committees at all
institutions/hospitals where participants were recruited [17]. The
GEO [22] accesion number (GSE20406) for this study has been
approved as well as GEO accession numbers for each of the
samples (Table 7).
Samples and candidate regions
As stated earlier, in a previous study we genotyped a total of 132
individuals from 41 non-BRCA1/2 families with almost 6,000
SNP markers, and we observed a linkage profile showing several
candidate regions. Suggestive linkage signals (HLOD .2.2) were
found in two regions located on chromosomes 3 and 6, which span
10.8 and 6.5 Mb, respectively, and we found 6 and 5 families
putatively linked to each region [17].
In the present study, 10 of these 11 families were selected based
on the availability of DNA (from at least 2 affected members per
family for a total of 22 DNA samples collected) to perform a
mutational screening via massive parallel sequencing. One family
(Family 21) was excluded from the final analysis because the DNA
library preparation of one of the members failed. However,
putatively truncating mutations (e.g. new stop codons or
modifications within essential splice sites, and indel variants) were
analysed for the remaining individual of this family (see Table S1).
We also sequenced DNA of 4 healthy individuals from Spanish
control population, which were pooled into a single control data
file. This pooled-control design presented several advantages,
Figure 1. Filtering process. Analysis pipeline used in the identification of the candidate variants. Left boxes correspond to processing of variants;
right box corresponds to coverage analysis. See text for details.
doi:10.1371/journal.pone.0009976.g001
Table 5. Summary of the variant filtering process.
Chr Family Individual SNPs
After
control
Shared by
family Undescribed Consequences Exonic
Candidate
SNPs (%)*
3 27 07S722 49 10 0 0 0 0 0 (0.00)
07S723 39 2
07S724 45 18
07S725 25 4
60 06-240 47 18 15 7 6 3 1 (6.67)
96-652 61 26
531 I-1408 38 15 5 2 1 1 0 (0.00)
I-904 66 42
713 07S635 50 32 8 4 5 2 1 (12.50)
07S636 46 24
6 11 96_265 96 36 17 5 12 1 0 (0.00)
04_168 81 35
40 07S581 93 40 26 8 32 7 3 (11.54)
07S576 96 53
929 I-3345 81 28 13 3 10 3 0 (0.00)
I-1627 75 34
990 I-1927 131 63 52 14 40 8 4 (7.69)
I-1928 119 54
1125 I-4347 99 33 11 2 7 0 0 (0.00)
I-2033 74 26
Average 71 30 16 5 13 3 1 (6.25)
The number of variants after each of the filtering steps is shown for the 9 non-BRCA1/2 families. The original SNPs were matched against the control pool as well as with
the other member/s of the family. Previously undescribed variants were then selected and consequences obtained using PerlAPI tools. Intronic consequences were
discarded and finally the variants were checked for homology.
*with respect to SNPs shared by family.
doi:10.1371/journal.pone.0009976.t005
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namely reduced repercussion of differential sample DNA degra-
dation, increased sample heterozygosity, and a balancing effect
over the number of reads per sample in the final control data,
leading to increased data homogeneity.
Sequencing and exon-capture
We used the Illumina single-end technique to perform the
sequencing process and an exon-capture protocol recently
published [16], which was divided into two steps:
a) Library construction. Genomic DNA (2.5 mg) was
fragmented by a triple sonication step. To optimise the
sequencing process, we used 5-base barcodes (#1: 59-GATCT-
39; #2: 59-ATCGT-39; #3: 59-TGTCT39; #4: 59-GTGAT-39)
linked to the ligated oligos, in order to be able to pool 3 or 4
individuals per array and to discriminate the sequences obtained
from each individual. After ligating the modified adaptors, 150–
300 bp fragments were selected by agarose gel electrophoresis and
purified. To obtain a suitable amount of product, multiple parallel
PCR reactions were carried out per sample.
b) Exon capture. A total of 142,983 60-mer probes were
designed to cover the 787 exonic regions and immobilized on high-
density tiling arrays, in order to capture the coding sequences of the
128 genes located in both candidate regions. We used 14 arrays to
perform the enrichment step for all the samples. A final amount of
20 mg of PCR product from 3–4 individuals was hybridised onto the
array, with several blocking agents, during 65 hours (see Figure 1).
After amplification of the eluted DNA, the enrichment was validated
by quantitative PCR (qPCR) using the product from 4 different arrays.
Data analysis
a) Alignment. After the identification of the sequences
belonging to each individual and before the alignment, we
removed the first five bases of every sequence corresponding to
each of the barcodes. We selected SOAP v1.0 to analyse our
dataset using the following parameters: a seed of 12 positions, gaps
allowed up to 12 bases, a maximum of 2 mismatches, and a
maximum of 5 repeated regions (reporting every region on which
the sequences matched equally), using the whole genome as
Table 6. Final candidate SNPs.
Chr Family Position (hg18) Gene Reference Variant QSa DSb Consequencec
Alamuth
predictiond Gene function
3 60 161301596 AC026118.17e A T 91/91 56/57 NCG Pseudogene
713 170284589 EVI1 [MIM:165215] A G 95/94 128/100 3UTR Hematopoietic
proliferation
protein, related
to acute myeloid
leukemia
6 40 152502855 SYNE1 [MIM:608441] C T 105/98 90/92 NSYN TOL A spectrin repeat
containing
protein
expressed in
skeletal and
smooth muscle,
and in peripheral
blood
lymphocytes,
that localizes to
the nuclear
membrane
151203125 PLEKHG1 C T 103/98 133/146 SYN S1186S Unknown
151713613 AKAP12 [MIM:604698] C T 98/96 185/183 SYN P700P Scaffold protein
in signal
transduction, is a
cell growth-
related protein
990 146761618 GRM1 C T 101/96 101/81 NSYN R584C AFF Metabotropic
glutamate
receptor
150087915 NUP43 T C 95/93 101/97 3UTR Part of a nuclear
pore complex,
mediating
bidirectional
transport of
macromolecules
between
cytoplasm and
nucleus
150205485 LRP11 T C 101/101 74/95 NSYN I312V NDB Unknown
151564223 AL451072.14e G A 93/98 119/116 NCG Non-coding RNA
Variants confirmed by direct sequencing are marked in bold.
a) Quality Score Ind1/Ind2, b) Depth Score Ind1/Ind2, c) NCG: Non-coding gene, SYN: Synonymous, 3UTR: 39 UTR, NSYN: Non-synonymous.
d) NDB: Not in database, AFF: predicted to affect the protein, TOL: predicted to be tolerated.
e) No MIM reference.
doi:10.1371/journal.pone.0009976.t006
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reference sequence. One of the main advantages of SOAP v1.0 is
its ability to identify short insertions and deletions (indels) in single-
end data, while maintaining all input information in the output
file. We developed a specific SNP caller written in the Perl
programming language to extract the information contained in the
SOAP output file. The whole analysis pipeline for re-sequencing
data is shown in Figure 1.
b) Coverage. To evaluate the homogeneity of the coverage,
we calculated the mean and the median of the depth for stretches
of 15 bases along the candidate regions. For each sample, we
obtained the index value (IS) for each 15-base fragment as:
IS~log2
MDFS=MDS
MDFC=MDC
,
where MDFS and MDFC are the median of the depth in a 15-base
fragment for the sample and the control pool respectively, andMDS
andMDC are the global median of the depth for the sample and the
control pool respectively. To select supposedly altered regions, we
calculated the upper and the lower thresholds as:
IS§MDSzStMDSz0:5
or
ISƒMDS{StMDS{0:5
where MDS is the global median and StMDS the standard
deviation of the depth for the sample. Finally, for these putatively
altered regions, we calculated the correlation between the mean
and the median of the depth to evaluate possible coverage gaps
within them.
c) Scores. To further select candidate heterozygous variants,
we calculated the mean quality (base-calling quality from Illumina
Genome Analyser) and the allele depth (number of different
sequences in which an allele appeared) for both the variant and the
reference alleles, and also the global depth (number of different
sequences that cover a single base). We calculated two different
scores based on the same mathematical formula:
score~
XV
XR
 
|100,
where XV represents the mean quality (for Quality Score
calculations) or the allele depth (for Depth Score calculations) of
the variant allele, and XR represents in each case the same
parameter but for the reference allele. Scores close to 100 indicate
that both alleles are equally represented.
In order to determine the optimal DS threshold for the analysis,
we performed a study using the information from a single family
(Table 3). We used different DS score values for the affected
individuals of Family 990 and for the control pool data. We
observed that the number of final candidate variants depended
mostly on the threshold used for the sample data, although the
false positive rate increased when using a DS threshold of 50 for
the control data. Taking into account the optimal False Positive/
False Negative detection rate and being as conservative as possible,
we finally selected a DS threshold of 50 for the samples and a DS
threshold of 14 for the control pool data (Table 3).
d) Variants. In the pipeline analysis (Figure 1), firstly those
variants with a global depth,MDS and a DS,50 were removed
from the sample files as an integral function of the newly-
developed SNP-caller. Homozygous variants were also discarded
since we expected low-frequency heterozygous variants to be the
causal variants. Similarly, variants presenting a DS ,14 in the
control file were discarded (see above for explanation). Only non-
common variants from the previous step were selected for
subsequent analysis. The next step was an intrafamilial
comparison, with which variants putatively segregating in each
family were obtained. Although the filtering process was
performed for both SNP and indel variants, from this point
onwards subsequent filters were applied to SNP variants only
because no indel variants were found that fulfilled the previous
conditions (Table S1). We developed a Perl tool to distinguish
between described and previously undescribed variants, and also
to obtain the consequences of every undescribed variant on the
known transcripts, via the Ensembl database through the PerlAPI
tools [23]. From this point onwards, intronic consequences where
filtered out for each affected individual. In order to rule out
possible false positives due to homology artefacts, each variant was
manually checked for homology using BLAT search [24]. The
following step was the confirmation of those variants that passed
all filters previously mentioned via Sanger sequencing. As a final
step, we used Alamut version 1.5 software to evaluate, in silico, how
non-synonymous variants would affect the functionality of the
respective candidate proteins (Figure 1).
In order to rule out the possibility that a truncating mutation
was detected in one member of a family but not in the others, we
analysed the truncating consequences (e.g. stop-gains and
alterations in essential splice sites) of the remaining SNPs after
comparison against the control pool data (Table S2).
Table 7. GEO accession numbers of the raw data from each
of the samples.
Family Individual Accesion Number
27 07S722 GSM511164
07S723 GSM511165
07S724 GSM511166
07S725 GSM511167
60 06-240 GSM511168
96-652 GSM511169
531 I-1408 GSM511170
I-904 GSM511171
713 07S635 GSM511172
07S636 GSM511173
11 96-265 GSM511175
04-168 GSM511174
40 07S581 GSM511177
07S576 GSM511176
929 I-3345 GSM511179
I-1627 GSM511178
990 I-1927 GSM511180
I-1928 GSM511181
1125 I-4347 GSM511183
I-2033 GSM511182
Control pool GSM511184
doi:10.1371/journal.pone.0009976.t007
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Finally, we compared the sensitivity of our scores with a
published reference, and for that we followed our analysis pipeline
using MAQ software in a subset of families applying no threshold
for MAQ variant score (Table 4).
Supporting Information
Figure S1 Correlations. Coverage along the candidate regions
was very high (98% on average) and no correlation between
coverage and the number of sequences obtained per individual
was observed (A), although we observed a logarithmic trend when
the number of sequences aligned to the candidate regions was used
(B). On the other hand, a strong correlation between the number
of sequences aligned to the candidate coding regions and the mean
depth was observed in our dataset (C). Failures in the capture step
were discarded since high correlations between the global mean
and the global median of the depth per individual (D) and between
the mean and the median of the depth in putatively altered 15-bp
regions for all the individuals (E) were observed (see text for
details).
Found at: doi:10.1371/journal.pone.0009976.s001 (0.13 MB
DOCX)
Table S1 Indel variant filtering process.
Found at: doi:10.1371/journal.pone.0009976.s002 (0.05 MB
DOCX)
Table S2 Putative truncating variants discarded during the
filtering process. A. Summary of the whole list of truncating
variants (STOP_GAINED and ESSENTIAL_SPLICE_SITE) in
some individuals after comparison to the control pool data. The
original list has been filtered (Depth Score . 50) for simplicity,
given that variants showing a Depth Score below the threshold are
likely to be false positives. As evidenced in the table, none of the
variants above the threshold has a high Global Depth value, which
paired to the fair Depth Score means that in every case the variant
allele was detected in a low proportion in relation to the respective
reference allele. Additionally, this table shows that no putative
candidate truncating variants were discarded during the filtering
process, reassuring that filtering using Depth Score and Global
Depth is a stringent but adequate filtering step. In conclusion, the
low Global Depth and Depth Scores explain why these variants
are likely to be false positive results and they were therefore
excluded from the final candidate SNP list (Table 6). B. The list of
truncating variants for sample 05_980. The other member of this
family failed in the library preparation step, but we still performed
the analysis of the variants. The most likely variant (in red) was
ruled out through Sanger sequencing.
Found at: doi:10.1371/journal.pone.0009976.s003 (0.15 MB
DOCX)
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